Tripentones: A promising series of potent anti-cancer agents

Anti-Cancer Agents in Medicinal Chemistry

Volumn 9, Issue 4, 2009, Pages 369-380

  Rochais, Christophe ^a   Dallemagne, Patrick ^a   Rault, Sylvain ^a  

^a CENTRE D ETUDES ET DE RECHERCHE SUR LE MÉDICAMENT DE NORMANDIE   (France)

Author keywords

Cancer; Pyrrolizinone; Pyrroloindolone; Thiophene; Tripentone

Indexed keywords

3 ARYL 8H THIENO[2,3 BETA]PYRROLIZIN 8 ONE DERIVATIVE; 5 HYDROXY 9H PYRROLOL[1,2 ALPHA]INDOL 9 ONE DERIVATIVE; 8 HYDROXY 9H PYRROLO[1,2 ALPHA]INDOL 9 ONE DERIVATIVE; 8H THIENO[2,3 BETA]PYRROLIZIN 8 ONE; 8H THIENO[2,3 BETA]PYRROLIZIN 8 ONE DERIVATIVE; 8H THIENO[3,4 BETA]PYRROLIZIN 8 ONE; 9H PYRROLO[1,2 ALPHA]INDOL 9 ONE; ANTINEOPLASTIC AGENT; CISPLATIN; DEOXYPODOPHYLLOTOXIN; HETEROCYCLIC TRIPENTONE; MR 16924; MR 22388; NANOPARTICLE; PYRAZOLE[4,3 BETA]PYRROLIZINE DERIVATIVE; PYRIDOPYRROLIZINONE DERIVATIVE; SPIROSUCCINIMIDE DERIVATIVE; TRIPENTONE DERIVATIVE; UNCLASSIFIED DRUG; MITOMYCIN;

ANTINEOPLASTIC ACTIVITY; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; DRUG SYNTHESIS; HUMAN; IC 50; LEUKEMIA; NONHUMAN; REVIEW; STRUCTURE ACTIVITY RELATION; SUSTAINED DRUG RELEASE; ANIMAL; DRUG SCREENING; LEUKEMIA L 1210; SYNTHESIS;

ANIMALS; ANTINEOPLASTIC AGENTS; DRUG SCREENING ASSAYS, ANTITUMOR; INHIBITORY CONCENTRATION 50; LEUKEMIA L1210; MITOMYCINS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 67649827562     PISSN: 18715206     EISSN: None     Source Type: Journal    
DOI: 10.2174/1871520610909040369     Document Type: Review

References (61)

1. Hata, T.; Yoshimoto, S.; Sugawara, R.; Matsumae, A.; Kanamori, K.; Shima, T.; Hoshi, T. Mitomycin, a new antibiotic from Streptomyces. J Antibiotics Ser. A., 1956, 9(4), 141-146.
2. Webb, J.S.; Cosulich, D.B.; Mowat, J.H.; Patrick, J.B.; Broschard, R.W.; Meyer, W.E.; Williams, R.P.; Wolf, C.F.; Fulmor, W.; Pidacks, D.; Lancaster, J.E. The structures of mitomycins A, B and C and porfiromycin-Part I. J. Am. Chem. Soc., 1962, 84 (16), 3185-3187.
3. Shirley, D.A.; Gross, B.H.; Roussel, P.A. Metalation of pyrrole, 1-methylpyrrole and 1-phenylpyrrole with n-butyllithium. J. Am. Chem. Soc., 1955, 77 (20), 225-231.
4. Kashulin, I.A.; Nifant'ev, I.E. Efficient method for the synthesis of hetareno-indanones based on 3-arylhetarenes and their conversion into hetarenoindenes. J. Org. Chem., 2004, 69 (16), 5476-5479.
5. Campo, M.A.; Larock, R.C. Synthesis of fluoren-9-ones by the palladium-catalyzed cyclocarbonylation of o-halobiaryls. J. Org. Chem., 2002, 67 (16), 5616-5620.
6. Josey, A.D.; Jenner, E.L. N-Functionnally substituted pyrroles. J. Org. Chem., 1962, 27 (7), 2466-2470.
7. Clauson-Kaas, N.; Tyle, Z. Preparation of cis and trans 2,5- dimethoxy-2-(acet-amidomethyl)-2,5-dihydrofurans, of cis and trans 2,5-dimethoxy-2-(acetamidomethyl) tetrahydrofuran and of 1-phenyl-2-(acetamidomethyl)pyrrole. Acta Chem. Scand., 1952, 6, 667-670.
8. Mazzola, V.J.; Bernardy, K.F.; Franck, R.W. 9H-pyrrolo[1,2-a]indoles. J. Org. Chem., 1967, 32 (2), 486-89.
9. Sugihara, H.; Matsumoto, N.; Kawamatsu, Y. Synthesis of pyrrolo[1,2-a]indole derivatives. Yukagaku Zasshi, 1974, 94, 181-188.
10. Sugihara, H.; Matsumoto, N.; Hamuro, Y.; Kawamatsu, Y. Oral hypoglycaemic agents. 1-(2-Carboxyphenyl)pyrroles. Arzneimittel-Forsch., 1974, 24, 1560-1563.
11. Kametani, T.; Takahashi, K. Synthesis of pyrrolo[1,2-a]indoles and related systems. Heterocycles, 1978, 9(3), 293-351.
12. Huisgen, R.; Laschtuvka, E. A new synthesis of derivatives of pyrrole. Chem. Ber., 1960, 93, 65-81.
13. Giuliano, R.; Porretta, G.C.; Scalzo, M.; Chimenti, F.; Artico, M.; Dolfini, E.; Morasca, L. Antiblastic substances. I. Synthesis, cytotoxicity activity of 9H-pyrrolo[1,2-a]indole derivatives. Farmaco. Edizione Sci., 1972, 27, 1091-1103.
14. Siuta, G.J.; Franck, R.W.; Ozorio, A.A. Meta photo-Fries reaction. J. Chem. Soc. Chem. Commun., 1974, 21, 910.
15. Crump, D.R.; Franck, R.W.; Gruska, R.; Ozorio, A.A.; Pagnotta, M.; Siuta, G.J.; White, J.G. Approaches to the mitomycins. A meta photo-Fries reaction. J. Org. Chem., 1977, 42 (1), 105-108.
16. Friary, R.J.; Gilligan, J.M.; Szajewski, R.P.; Falci, K.J.; Franck, R.W. Heterocyclic syntheses via the intramolecular acylation of enamines derived from amino acids. J. Org. Chem., 1973, 33 (20), 3487-3491.
17. Kametani, T.; Ohsawa, T.; Takahashi, K.; Ihara, M.; Fukumoto, K. Photo-oxygenation of 9-keto-7-methoxy-6-methyl-9H-pyrrolo[1,2-a]indole as a synthetic approach to the mitomycine. Heterocycles, 1976, 4(10), 1637-1644.
18. Rault, S.; Cugnon de Sevricourt, M.; Godard, A.; Robba, M. A Convenient synthesis of new aminopyrroloindoles via an iminium salt. Tetrahedron Lett., 1985, 26 (19), 2305-2308.
19. Bouyazza, L.; Lancelot, J.C.; Rault, S.; Robba, M.; Quermonne, M.A. A Convenient synthesis of new aminomethylenedioxypyrroloindoles via an iminium salt, J. Heterocycl. Chem., 1991, 28, 373-377.
20. Kobayashi, K.; Himei, Y.; Fukamachi, S.; Tanmatsu, M.; Morikawa, O.; Konishi, H. Synthesis of 9-arylamino- and (Z)-9-arylimino-9H-pyrrolo[1,2-[i a]indoles by reaction of 2-(pyrrol-1-yl)benzaldehydes with aryl amines. Tetrahedron, 2007, 63 (20), 4356-4359.
21. Rault, S.; Lancelot, J.C.; Effi, Y.; Robba, M. Thiénopyrrolizines: New condensed triheterocyclic systems. Heterocycles, 1983, 20 (3), 477-480.
22. Reinhoudt, D.N.; Trompenaars, W.P.; Geevers, J. Reactions of thiophenes with acetylenes in polar solvents; a novel annulation reaction. Tetrahedron Lett., 1976, 17 (51), 4777-4780.
23. Rochais, C.; Lescot, E.; Lisowski, V.; Lepailleur, A.; Sopkova de Oliveira-Santos, J.; Bureau, R.; Dallemagne, P.; Meijer, L.; Rault, S. Synthesis and biological evaluation of thienopyrrolizines, a new family of CDK/GSK-3 inhibitors. J. Enzyme Inhib. Med. Chem., 2004, 19(6), 585-593.
24. Ladurée, D.; El Kashef, H.; Robba, M. Synthesis of 9H-pyrrolo [1,2-a]-1,4-diazaindol-9-one. Heterocycles, 1984, 22(2), 299-301.
25. Massa, S.; Mai, A.; Artico, M. Heterocyclic system. XI. Synthesis of 1 H,4H-pyrazolo[4,3-b]pyrrolizine and 2H,4H-pyrazolo[4,3-[i b]pyrrolizine derivatives. Heterocycl. Chem., 1990, 27, 1805-1808.
26. Peinador, C.; Veiga, M.C.; Vilar, J.; Quintela, J.M. A synthesis of heterocyclic ring systems. Pyrido[3′,2′:4,5]thieno[2,3-b]pyrrolizine and pyrido[6′, 5′:4,5] [3′, 2′:4,5] di-thieno[2,3-[i b':2,3-b]dipyrrolizine. Heterocycles, 1994, 38 (6), 1299-1305.
27. Ladurée, D.; Robba, M. Synthesis of 5H-pyrrolo[1,2-a]-1-azaindole and derivatives. Heterocycles, 1984, 22 (2), 303-305.
28. York, B.M. Spiro-tricyclicaromatic succinimide derivatives as inhibitors of aldose-reductase. European Patent Appl. 84110855.8, 1984.
29. Teleha, A.C.; Wilkerson, W.W. Novel polycyclic systems, and deriveratives thereof, as neurotransmitter release enhancers useful in the treatment of cognitive disorders. World Patent Appl. 24131, 1994.
30. Rault, S.; Lancelot, J.C.; Bouyazza, L.; Robba, M.; Quermonne, M.A.; Nammathao, B.; Louchahi-Raoul, J.; Marcy, R. Synthèse et étude préliminaire de l'activité psychotrope d'alkylamino et iminopyrrolo[1,2-a] indoles. Eur. J. Med. Chem. 1991, 26 (9), 939-946.
31. Baglin, I.; Daveu, C.; Lancelot, J.C.; Bureau, R.; Dauphin, F.; Pfeiffer, B.; Renard, P.; Delagrange, P.; S. Rault. First tricyclic oximino derivatives as 5-HT3 ligands. Bioorg. Med. Chem. Lett., 2001, 11 (4), 453-457.
32. Bureau, R.; Daveu, C.; Baglin, I.; Sopkova-de Oliveira Santos, J.; Lancelot, J.C.; Rault, S. Association of two 3D QSAR analyses. Application to the study of partial agonist serotonin-3 ligands. J. Chem. Inf. Comput. Sci., 2001, 41 (3), 815-823.
33. Bureau, R.; Daveu, C.; Lancelot, J.C.; Rault, S. Molecular design based on 3D- pharmacore. Application to 5-HT subtypes receptors. J. Chem. Inf. Comput. Sci., 2002, 42 (2), 429-436.
34. Lepailleur, A.; Bureau, R.;Lemaître, S.; Dauphin, F.; Lancelot, J.C.; Contesse, V.; Lenglet, S.; Delarue, C.; Vaudry, H.; Rault, S. Molecular design based on 3-D pharmacophore. Application to 5-HT7 receptors. J. Chem. Inf. Comput. Sci., 2004, 44 (3), 1148-1152.
35. Lisowski, V.; Enguehard, C.; Lancelot, J.C.; Caignard, D.H.; Lambel, S.; Leonce, S.; Pierre, A.; Atassi, G.; Renard, P.; Rault, S. Design, synthesis and antiproliferative activity of tripentones: A new series of antitubulin agents. Bioorg. Med. Chem. Lett., 2001, 11(16), 2205-2208.
36. Lisowski, V.; Léonce, S.; Kraus-Berthier, L.; Sopkova-de-Oliveira Santos, J.; Pierré, A.; Atassi, G.; Caignard, D.H.; Renard, P.; Rault, P. Design, synthesis and evaluation of a novel thienopyrrolizinone series as antitubulin agents. J. Med. Chem., 2004, 47 (6), 1448-1464.
37. Fiesselman, H. Uber hydroxy- und aminothiophene (On hydroxy- and aminothiophene). Angew. Chem., 1959, 11, 377.
38. Kirsch, G.; Cagniant, D.; Cagniant, P. Synthesis of 3-aminothiophenes from aryl and hetarylacetonitrile. J. Heterocycl. Chem., 1982, 19, 443-445.
39. Rault, S.; Lancelot, J.C.; Letois, B.; Robba, M.; Labat, Y. New derivatives of 3-mercapto-2-thenoic acid and process for their preparation. French Patent Appl. 9203732, 1992.
40. Lancelot, J.C.; Letois, B.; Rault, S.; Robba, M.; Rogosca, M. Thienopyrrolizines: new condensed triheterocyclic systems. J. Heterocycl. Chem., 1994, 31, 501-504.
41. Tarzia, G.; Panzone, G.; De Paoli, A.; Schiatti, P.; Selva, D. Antiinflammatory properties of a series of 4-amino-5-arylpyrazoles. Farmaco. Edizione Sci., 1984, 39, 618-636.
42. Rochais, C.; Lisowski, V.; Dallemagne, P.; Rault, S. First synthesis of arylpyrrolo-and pyrazolopyrrolizinones as useful agents with potential biological interest. Tetrahedron Lett., 2004, 45 (33), 6353-6355.
43. Rochais, C.; Sopkova-de Oliveira Santos, J.; Dallemagne, P.; Rault, S. Synthesis of novel pyrazolopyrrolizinones as prospective anticancer agents. Heterocycles, 2006, 68 (10), 2063-2077.
44. Rochais, C.; Lisowski, V.; Dallemagne, P.; Rault, S. First synthesis of methyl 3-amino-4-(het)aryl-1H-pyrrole-2-carboxylates as useful scaffolds in medicinal chemistry. Tetrahedron, 2004, 60 (9), 2267-2270.
45. Rochais, C.; Lisowski, V.; Dallemagne, P.; Rault, S. Synthesis and biological evaluation of novel pyrrolopyrrolizinones as anticancer agents. Bioorg. Med. Chem., 2006, 14 (24), 8162-8175.
46. Lisowski, V.; Vu, D.N.; Feng, X.; Rault, S. Preparation of new ethyl 3-amino-4-arylfurane-2-carboxylates. Synthesis, 2002, 65 (6), 753-756.
47. Lisowski, V.; Robba, M.; Rault, S. Efficient synthesis of new 3-(het) aryl-anthranilic acids via a Susuki cross couping reaction of 7-iodoisatin with (het) arylboronic acids in water. J. Org. Chem., 2000, 65 (13), 4193-4194.
48. Guo, S.; Zhao, Y.; Zhao, X.; Zhang, S.; Xie, L.; Kong, W., Gong, P. Synthesis and anti-tumor activities of novel methylthio-, sulfinyl-, and sulfonyl-8H-thieno[2,3-b]pyrrolizin-8-oximino derivatives. Arch. Pharm. Chem. Life. Sci., 2007, 340 (8), 416-423.
49. Guo, S.; Zhao, Y.; Li, R.; Xie, L.; Yang, Y.; Gong, P. Synthesis and biological evaluation of novel tricyclic oximino derivatives as antitumor agents. Chem. Res. Chin. Univ., 2008, 24 (1), 47-53.
50. Rault, S.; Robba, M.; Lancelot, J.C.; Prunier, H.; Renard, P.; Pfeiffer, B.; Guardiola-Lemaitre, B.; Rettori, M.C. Tricyclic oxime ether process for their preparation and pharmaceutical compositions containing them. Eur. Pat. Appl. 0718299A1, 1996.
51. Rault, S.; Enguehard, C.; Lancelot, J.C.; Robba, M.; Atassi, G.; Pierré, A.; Caignard, D.H.; Renard, P. Fr. Pat. Appl. 09552, 1998; Eur. Patent 0982308, 2000; Jpn. Kokai Tokkyo Koho 044572, 2000.
52. Jordan, M.A. Mechanism of action of antitumor drugs that interact with microtubules and tubulin. Curr. Med. Chem. Anticancer Agents, 2002, 2 (1), 1-17.
53. Li, Q.; Sham, H.L. Discovery and development of antimitotics agents that inhibit tubulin polymerisation for the treatment of cancer. Expert Opin. Ther. Patents, 2002, 12 (11), 1663-1702.
54. Pettit, G.R.; Singh, S.B.; Hamel, E.; Lin, C.M.; Alberts, D.S.; Garcia-Kendall, D. Isolation and structure of the strong cell growth and tubulin inhibitor combretastatin A-4. Experitientia, 1989, 45(2), 209-211.
55. Chen, Z.; Merta, P.J.; Lin, N.H.; Tahir, S.K.; Kovar, P.; Sham, H.L.; Zhang, H. A-432411, a novel indolinone compound that disrupts spindle pole formation and inhibits human cancer cell growth. Mol. Cancer Ther., 2005, 4(4), 562-568.
56. Prinz, H.; Ishii, Y.; Hirano, T.; Stoiber, T.; Camacho-Gomez, J.A.; Schmidt, P.; Dussman, H.; Burger, A.M.; Prehn, J.H.; Günther, E.G.; Umezawa, K. Novel benzylidene-9(10H)-anthracenones as highly active antimicrotubule agents. Synthesis, antiproliferative activity, and inhibition of tubulin polymerization. J. Med. Chem., 2003, 46(15), 3382-3394.
57. Zuse, A.; Schmidt, P.; Baasner, S.; Böhm, K.J.; Müller, K.; Gerlach, M.; Günther, E.G.; Unger, E.; Prinz, H. Sulfonate derivatives of naphtho[2,3-b]thiophen-4(9H)-one and 9(10H)-anthracenone as highly active antimicrotubule agents. Synthesis, anti-proliferative activity, and inhibition of tubulin polymerization. J. Med. Chem., 2007, 50 (24), 6059-6066.
58. Malzert-Freon, A.; Vrignaud, S.; Saulnier, P.; Lisowski, V.; Benoît, J.P.; Rault, S. Formulation of substained release nanoparticles loaded with a tripentone, a new anticancer agent. Int. J. Pharm., 2006, 320, 157-164.
59. Honma, T.; Hayashi, K.; Aoyama, T.; Hashimoto, N; Machida, T.; Fukasawa, K.; Iwama, T.; Ikeura, C.; Ikuta, M.; Suzuki-Takahashi, I.; Iwasawa, Y.; Hayama, T.; Nishimura, S.; Morishima, H. Structure-based generation of a new class of potent Cdk4 inhibitors: new de novo design strategy and library design. J. Med. Chem., 2001, 44 (26), 4615-4627.
60. Kawanishi, N.; Sugimoto, T.; Shibata, J., Nakamura, K.; Masutani, K.; Ikuta, M. Hirai, H. Structure-based drug design of a highly potent CDK1,2,4,6 inhibitor with novel macrcyclic quinoxalin-2-one structure. Bioorg. Med. Chem. Lett., 2006, 16 (19), 5122-5126.
61. 3D-QSAR and docking studies of selectives GSK-3 inhibitors. Comparison with a thieno[2,3-b]pyrrolizinones derivative, a new potential lead for GSK-3 Ligands. [i J. Chem. Inf. Model., 2005, 45 (3), 708-715.